FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
Cystic fibrosis (CF) is the most common inherited metabolic disease in Europe. More than 8,000 people in Germany are affected ...
The Phase 2 study is a multi-center, randomized, partially double-blind, placebo- and active-controlled trial designed to evaluate the efficacy, safety, and pharmacokinetics of oral AK3280 in patients ...
Every person with idiopathic pulmonary fibrosis experiences it differently, making each patient's journey unique, says columnist Sam Kirton.
Treatment with Esbriet, a drug approved for people with idiopathic pulmonary fibrosis, was found to ease heart stiffness and rhythm issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results